The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1302-1305 , October 2004

SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML

REFERENCES 

  1. Hankey BF , Feuer EJ , Clegg LX , Hayes RB , Legler JM , Prorok PC , et al.   Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates . J Natl Cancer Inst . 1999;91:1017
  2. Ornstein DK , Pruthi RS . Prostate-specific antigen . Expert Opin Pharmacother . 2000;1:1399
  3. Catalona WJ , Partin AW , Slawin KM , Brawer MK , Flanigan RC , Patel A , et al.   Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial . JAMA . 1998;279:1542
  4. Brawer MK , Cheli CD , Neaman IE , Goldblatt J , Smith C , Schwartz MK , et al.   Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer . J Urol . 2000;163:1476
  5. Wulfkuhle JD , Liotta LA , Petricoin EF . Proteomic applications for the early detection of cancer . Nat Rev Cancer . 2003;3:267
  6. Liotta LA , Ferrari M , Petricoin E . Clinical proteomics: written in blood . Nature . 2003;425:905
  7. Davies HA . The ProteinChip System from Ciphergen: a new technique for rapid, micro-scale protein biology . J Mol Med . 2000;78:B29
  8. Issaq HJ , Conrads TP , Prieto DA , Tirumalai R , Veenstra TD . SELDI-TOF MS for diagnostic proteomics . Anal Chem . 2003;75:148A
  9. Paweletz CP , Trock B , Pennanen M , Tsangaris T , Magnant C , Liotta LA , et al.   Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer . Dis Markers . 2001;17:301
  10. von Eggeling F , Junker K , Fiedle W , Wollscheid V , Durst M , Claussen U , et al.   Mass spectrometry meets chip technology: a new proteomic tool in cancer research? . Electrophoresis . 2001;22:2898
  11. Li J , Zhang Z , Rosenzweig J , Wang YY , Chan DW . Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer . Clin Chem . 2002;48:1296
  12. Petricoin EF , Liotta LA . Mass spectrometry-based diagnostics: the upcoming revolution in disease detection . Clin Chem . 2003;49:533
  13. Conrads TP , Zhou M , Petricoin EF , Liotta L , Veenstra TD . Cancer diagnosis using proteomic patterns . Expert Rev Mol Diagn . 2003;3:411
  14. Adam BL , Qu Y , Davis JW , Ward MD , Clements MA , Cazares LH , et al.   Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men . Cancer Res . 2002;62:3609
  15. Petricoin EF , Zoon KC , Kohn EC , Barrett JC , Liotta LA . Clinical proteomics: translating benchside promise into bedside reality . Nat Rev Drug Discov . 2002;1:683
  16. Petricoin EF , Ardekani AM , Hitt BA , Levine PJ , Fusaro VA , Steinberg SM , et al.   Use of proteomic patterns in serum to identify ovarian cancer . Lancet . 2002;359:572
  17. Petricoin EF , Ornstein DK , Paweletz CP , Ardekani A , Hackett PS , Hitt BA , et al.   Serum proteomic patterns for detection of prostate cancer . J Natl Cancer Inst . 2002;94:1576
  18. Paweletz CP , Liotta LA , Petricoin EF . New technologies for biomarker analysis of prostate cancer progression: laser capture microdissection and tissue proteomics . Urology . 2001;57:160
  19. Cazares LH , Adam BL , Ward MD , Nasim S , Schellhammer PF , Semmes OJ , et al.   Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry . Clin Cancer Res . 2002;8:2541
  20. Ahram M , Flaig MJ , Gillespie JW , Duray PH , Linehan WM , Ornstein DK , et al.   Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications . Proteomics . 2003;3:413

 Accepted for publication May 21, 2004.Study received institutional review board approval.

PII: S0022-5347(05)61156-1

doi: 10.1097/01.ju.0000139572.88463.39

The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1302-1305 , October 2004

Article Tools

* Image Usage & Resolution